Wave Life Sciences (WVE) Operating Leases (2016 - 2025)
Historic Operating Leases for Wave Life Sciences (WVE) over the last 9 years, with Q3 2025 value amounting to $11.4 million.
- Wave Life Sciences' Operating Leases fell 4245.4% to $11.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.4 million, marking a year-over-year decrease of 4245.4%. This contributed to the annual value of $17.8 million for FY2024, which is 3006.61% down from last year.
- Wave Life Sciences' Operating Leases amounted to $11.4 million in Q3 2025, which was down 4245.4% from $13.6 million recorded in Q2 2025.
- Wave Life Sciences' 5-year Operating Leases high stood at $35.2 million for Q2 2022, and its period low was $11.4 million during Q3 2025.
- Moreover, its 5-year median value for Operating Leases was $23.6 million (2022), whereas its average is $24.0 million.
- Per our database at Business Quant, Wave Life Sciences' Operating Leases soared by 4978.42% in 2022 and then tumbled by 4245.4% in 2025.
- Over the past 5 years, Wave Life Sciences' Operating Leases (Quarter) stood at $25.0 million in 2021, then grew by 28.7% to $32.1 million in 2022, then decreased by 20.9% to $25.4 million in 2023, then crashed by 30.07% to $17.8 million in 2024, then tumbled by 35.96% to $11.4 million in 2025.
- Its Operating Leases stands at $11.4 million for Q3 2025, versus $13.6 million for Q2 2025 and $15.7 million for Q1 2025.